Page last updated: 2024-10-28

fasudil and Leukemia, Megakaryocytic

fasudil has been researched along with Leukemia, Megakaryocytic in 1 studies

fasudil: intracellular calcium antagonist; structure in first source
fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.

Research Excerpts

ExcerptRelevanceReference
"Acute megakaryocytic leukemia (AMKL) is a rare neoplasm caused by abnormal megakaryoblasts."1.91Fasudil promotes polyploidization of megakaryoblasts in an acute megakaryocyte leukemia model. ( Gao, Y; He, B; Niu, J; Wang, C; Wang, F; Yang, Q; Zhang, Y, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
He, B1
Wang, C1
Niu, J1
Wang, F1
Zhang, Y1
Gao, Y1
Yang, Q1

Other Studies

1 other study available for fasudil and Leukemia, Megakaryocytic

ArticleYear
Fasudil promotes polyploidization of megakaryoblasts in an acute megakaryocyte leukemia model.
    Naunyn-Schmiedeberg's archives of pharmacology, 2023, Volume: 396, Issue:11

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Leukemia, Megakaryoblastic, Acute; Megakaryo

2023